| Test Number
| Components
| Reference Interval
|
| 0040080 | Hematocrit
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6-23 months
| 2-5 years
| 6-11years
| 12 years and older
| | Male %
| 43.4-56.1%
| 40.2-54.7%
| 33.7-55.1%
| 29.7-44.2%
| 26.2-35.3%
| 28.7-36.1%
| 30.9-37.0%
| 31.7-37.7%
| 32.7-39.3%
| 40.8-51.9%
| | Female %
| 37.4-55.9%
| 39.1-56.7%
| 36.4-51.2%
| 30.6-44.7%
| 26.3-36.6%
| 28.5-36.1%
| 31.2-37.2%
| 32.0-37.1%
| 33.0-36.9%
| 34.3-46.6%
|
|
| 0040085 | Hemoglobin
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6 - 23 months
| 2-5 years
| 6-11 years
| 12 years and older
| | Male (g/dL)
| 14.7-18.6
| 13.4-17.9
| 11.1-16.7
| 9.9-14.9
| 8.9-11.9
| 9.7-12.2
| 10.3-12.4
| 10.5-12.7
| 11.0-13.3
| 14.6-17.8
| | Female (g/dL)
| 12.7-18.3
| 12.2-18.7
| 11.9-16.9
| 10.5-14.7
| 8.9-12.3
| 9.7-12.0
| 10.4-12.4
| 10.7-12.7
| 10.9-13.3
| 12.1-15.9
|
|
| 0040270 | Red Blood Cell Count
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6 - 23 months
| 2-5 years
| 6-11 years
| 12 years and older
| | Male (M/µL)
| 4.20-5.50
| 3.90-5.40
| 3.40-5.10
| 3.10-4.60
| 2.90-3.90
| 3.50-4.70
| 4.10-5.00
| 4.00-4.90
| 4.00-4.90
| 4.69-6.07
| | Female (M/µL)
| 3.40-5.40
| 3.50-5.50
| 3.20-5.00
| 3.10-4.60
| 2.90-4.10
| 3.40-4.60
| 4.10-4.90
| 4.00-4.90
| 4.00-4.90
| 3.88-5.46
|
|
| 0040320 | White Blood Cell Count
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6-23 months
| 2-5 years
| 6-11 years
| 12 years and older
| | Male (K/µL)
| 6.8-13.3
| 8.3-14.1
| 8.2-14.4
| 7.4-14.6
| 6.7-14.2
| 6.9-15.7
| 6.2-14.5
| 5.3-11.5
| 4.5-10.5
| 3.2-10.6
| | Female (K/µL)
| 8.0-14.3
| 8.8-14.8
| 8.4-15.4
| 8.3-14.7
| 7.0-15.1
| 6.8-16.0
| 6.4-15.0
| 5.3-11.5
| 4.7-10.3
| 3.2-10.6
|
|
| | RDW
| 12 years and older: 10.8-14.1%
|
| | MPV
| 12 years and older: 5.9-9.8 fL
|
| | MCV
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6-23 months
| 2-5 years
| 6-11 years
| 12 years and older
| | Male (fL)
| 97.3-109.8
| 95.5-109.3
| 93.1-105.4
| 88.7-101.2
| 84.6-95.4
| 73.6-86.6
| 70.5-81.2
| 72.7-83.6
| 75.9-86.5
| 77.8-94.0
| | Female (fL)
| 99.4-113.8
| 97.9-111.6
| 97.3-109.3
| 91.8-102.5
| 85.0-96.9
| 74.7-87.6
| 71.5-81.8
| 73.8-84.3
| 76.8-87.6
| 77.8-94.0
|
|
| | MCH
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 0.2-2 years
| 2-6 years
| 6-12 years
| > 12 years
| | Male (pg)
| 32.5-36.5
| 31.1-36.5
| 30.6-35.7
| 30.1-33.8
| 28.4-32.6
| 24.5-29.1
| 23.2-27.5
| 24.1-28.4
| 25.4-29.4
| 26.5-32.6
| | Female (pg)
| 32.6-37.8
| 32.2-36.6
| 31.7-36.5
| 30.8-34.6
| 28.6-32.9
| 24.7-29.6
| 23.5-27.6
| 24.3-28.6
| 25.4- 29.6
| 26.5-32.6
|
|
| | MCHC
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6-23 months
| 2-5 years
| 6-11 years
| 12 years and older
| | Male (g/dL)
| 32.1-34.2
| 32.0-34.6
| 32.0-35.0
| 32.3-35.0
| 32.5-35.5
| 32.0-35.1
| 31.9-35.0
| 31.9-35.1
| 32.2-35.2
| 32.7-36.9
| | Female (g/dL)
| 31.6-34.7
| 31.8-34.6
| 32.1-34.8
| 32.0-35.0
| 32.2-35.3
| 32.0-35.1
| 31.8-34.8
| 31.9-35.0
| 31.9-35.0
| 32.7-36.9
|
|
| | Granulocytes Number
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6-23 months
| 2-5 years
| 6-11 years
| 12 years and older
| | Male (K/µL)
| 1.7-4.7
| 1.9-4.1
| 1.9-5.2
| 1.5-3.6
| 1.2-4.4
| 1.4-6.4
| 1.6-8.3
| 1.8-7.4
| 1.8-6.6
| 1.3-7.0
| | Female (K/µL)
| 2.1-8.4
| 1.8-5.1
| 1.7-5.4
| 1.3-4.3
| 1.2-4.9
| 1.4-6.7
| 1.8-9.1
| 1.8-6.8
| 1.8-6.7
| 1.3-7.0
|
|
| | Granulocytes Percentage
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6-23 months
| 2-5 years
| 6-11 years
| 12 years and older
| | Male
| 24.1-50.3%
| 18.4-36.3%
| 18.3-36.3%
| 14.7-35.3%
| 14.2-40.0%
| 1.36-51.6%
| 21.3-66.7%
| 30.3-74.3%
| 36.3-74.3%
| 44.0-76.0%
| | Female
| 23.1-58.4%
| 18.0-35.0%
| 17.1-33.1%
| 13.5-41.6%
| 13.6-44.5%
| 16.3-53.6%
| 22.2-67.1%
| 30.4-73.3%
| 37.4-77.1%
| 44.0-76.0%
|
|
| | Eosinophils Number
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 0.5-2 years
| 2-6 years
| 6-12 years
| > 12 years
| | Male K/µL
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| 0.0-0.4
| | Female K/µL
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| 0.0-0.4
|
|
| | Eosinophils Percentage
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6-23 months
| 2-5 years
| 6-11 years
| 12 years and older
| | Male %
| 0.0-8.0
| 0.0-5.9
| 0.0-6.9
| 0.0-6.4
| 0.0-5.7
| 0.0-4.6
| 0.0-3.3
| 0.0-4.3
| 0.0-5.8
| 0.0-6.0
| | Female %
| 0.0-5.6
| 0.0-5.1
| 0.0-5.6
| 0.0-5.1
| 0.0-4.7
| 0.0-3.7
| 0.0-3.0
| 0.0-4.3
| 0.0-5.8
| 0.0-6.0
|
|
| | Basophil Number
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6-23 months
| 2-5 years
| 6-11 years
| 12 years and older
| | Male K/µL
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| 0.0-0.1
| | Female K/µL
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| 0.0-0.1
|
|
| | Basophil Percentage
| 0-2%
|
| | Monocytes Number
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6-23 months
| 2-5 years
| 6-11 years
| 12 years and older
| | Male K/µL
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| 0.2-0.7
| | Female K/µL
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| NA
| 0.2-0.7
|
|
| | Monocytes Percentage
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6-23 years
| 2-5 years
| 6-11 years
| 12 years and older
| | Male
| 7-13%
| 8-13%
| 6-13%
| 7-14%
| 6-14%
| 5.-13%
| 5-11%
| 4-9%
| 4-9%
| 4-8.9%
| | Female
| 8-13%
| 6-12%
| 7-14%
| 6-16%
| 6-16%
| 5-12%
| 4-11%
| 4-9%
| 4-8%
| 4-8.9%
|
|
| | Lymphocytes Number
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6-23 months
| 2-5 years
| 6-11 years
| 12 years and older
| | Male K/µL
| 2.2-5.4
| 4.3-7.7
| 4.2-7.4
| 3.9-8.5
| 3.3-8.3
| 2.8-8.3
| 1.9-6.8
| 1.3-4.7
| 1.1-3.4
| 0.8-3.1
| | Female K/µL
| 2.8-5.3
| 4.9-7.0
| 4.4-8.3
| 4.1-8.9
| 3.2-9.1
| 2.8-8.4
| 1.2-7.0
| 1.4-4.7
| 1.1-3.5
| 0.8-3.1
|
|
| | Lymphocytes Percentage
| | Age
| 1-3 days
| 4-7 days
| 8-14 days
| 15-30 days
| 31-60 days
| 61-180 days
| 6-23 months
| 2-5 years
| 6-11 years
| 12 years and older
| | Male
| 26-57%
| 39-61%
| 40-62%
| 41-65%
| 40-70%
| 32-69%
| 20-64%
| 14-55%
| 14-48%
| 15-43%
| | Female
| 28-55%
| 39-64%
| 45-67%
| 35-67%
| 37-70%
| 30-69%
| 20-63%
| 16-56%
| 13-48%
| 15-43%
|
|